Gothamist

A non-profit newsroom, powered by WNYC.

Gothamist

WNYC Listen Live

Donate

 

 

News

Abortion meds still available through telehealth in NY after court restricts mifepristone


By

Ryan Kost

Published May 2, 2026


Share

FacebookTwitterRedditEmail


Never miss a story

 Email address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .

A box of mifepristone

 

Shuran Huang for The Washington Post via Getty Images


By

Ryan Kost

Published May 2, 2026


Share

FacebookTwitterRedditEmail


We rely on your support to make local news available to all

Make your contribution now and help Gothamist thrive in 2026. Donate today

Gothamist is funded by sponsors and member donations

A federal appeals court ruling that prohibits mailing the most common abortion pill nationwide will not immediately disrupt medication abortion access in New York City, providers say. Instead, they’ll mail a different medication.

A panel of the 5th U.S. Circuit Court of Appeals in New Orleans ruled unanimously Friday that mifepristone, one of two drugs used in most medication abortions, may only be prescribed and distributed in person. The ruling stems from a lawsuit brought by Louisiana that argued remote prescriptions undermined the state’s abortion ban.

In response, Planned Parenthood of Greater New York said it would continue mailing abortion medication through its Planned Parenthood Direct app, but would switch to misoprostol-only prescription kits, instead of having patients take mifepristone and then follow with misoprostol a few days later. The organization described misoprostol as a safe and effective option used worldwide to end early pregnancies.

The court’s ruling came the same day Planned Parenthood announced it would expand its telehealth abortion services by allowing patients to access prescriptions through its Planned Parenthood Direct app. Patients could then have the medication shipped overnight.

“Today’s decision is rooted in anti-abortion politics, not health care,” said Wendy Stark, the organization's president and CEO. “Using mifepristone for medication abortion is safe, effective, and backed by decades of research. Whether a patient picks up the medication at a health center or pharmacy, or receives it by mail, does not change those facts.”

New York City Health and Hospitals has also been offering medication abortion by mail since after telehealth consultation since late 2023, when it became the first public health system in the country to offer the option. The agency did not immediately respond to questions about how the ruling would affect its services, however its website indicates it will likely respond similarly to Planned Parenthood.

“In the current political climate, the legal aspect of the abortion is everchanging,” the agency website reads. “We will adapt our protocols and medications as needed to comply with the law, continuing to offer safe and effective options based on research and science.”

It outlines a medication regimen consisting only of misoprostol, in the event access to mifepristone is unavailable.

The Louisiana ruling is expected to be appealed to the Supreme Court, which overturned abortion as a nationwide right in 2022 but unanimously preserved access to mifepristone two years later. Mifepristone manufacturer Danco Laboratories has asked the 5th Circuit to pause the ruling for seven days to allow time for that appeal. The FDA first determined mifepristone was safe and effective more than 20 years ago.

Medication abortions have been growing as a percentage of overall abortions in the United States following the Dobbs decision. They accounted for roughly 65% of all clinician-provided abortions in the United States in 2023, according to the Guttmacher Institute, a pro-abortion-rights research group.

Tagged

Health and Science

Politics

new york state


Ryan Kost

Ryan Kost is a reporter on the day-of news desk, where he covers breaking news and writes enterprise stories about jails, courts, prosecutors and government accountability. His work focuses on the public institutions that shape life in New York. Before joining the newsroom, he lead a multi-part investigation with Columbia Journalism Investigations and New York Focus into how New York prosecutors handle wrongful conviction claims. He's also been a staff writer at The San Francisco Chronicle, The Associated Press and The Oregonian. Got a tip? Signal: ryankost.20

Read more

Gothamist is funded by sponsors and member donations


Gothamist is funded by sponsors and member donations


MORE news

Central Park birders, others remember 63-year-old woman killed in park

People who said they knew her described her as an artist and a familiar presence in the Ramble.

By

Charles Lane

Published Sep 28, 2026 at 7:04 p.m. ET


Dump truck driver hits and kills cyclist on 34th Street in Midtown, NYPD says

It's the latest in a string of hit-and-run deaths in the city in recent months.

By

Liam Quigley

News

Dump truck driver hits and kills cyclist on 34th Street in Midtown, NYPD says

It's the latest in a string of hit-and-run deaths in the city in recent months.

By

Liam Quigley


New ingredient mandated for Latin American kitchen, restaurant plates in NJ

By

Arya Sundaram

A Brooklyn jail cell filled with smoke. The emergency button failed, a lawyer said.

By

Samantha Max

Crews launch tunnel machines to dig first new Hudson River rail tunnels since 1910

By

Michael Sol Warren


Never miss a story

Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.

Sign upEmail address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .